Income before deduction of interest, taxes and amortization: HeartBeam Inc (BEAT)

Brandmark of heartbeam.com (BEAT)

HeartBeam, Inc. (BEAT) EBITDA_Co dynamics demonstrate the current cash result of the business, where the indicator level stands at 0.00. Exclusive patents for 3D-ECG and strict FDA certifications serve as a defense for HeartBeam, Inc. (BEAT). The company generates revenue from the sale of portable sensors and cloud-based AI analysis. Demand for cardiac diagnostics is independent of seasonality or crises, ensuring maximum resilience to external shocks.

HeartBeam Corporation - BEAT Operating profit EBITDA (period 11/23/2025 - 11/10/2026)

HeartBeam (BEAT) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price HeartBeam Corporation|BEAT - Price Target Chart
- company stock exchange capitalization indicators:
Market Value HeartBeam|BEAT - Real Price to Acquire Entire Company
- book capitalization information:
Book Price of a Share HeartBeam|BEAT - Book Capitalization|Market Value to Book Value Ratio heartbeam.com|BEAT - Company Total Assets
- company total debt and liquidity indicators:
Debt to Capital HeartBeam, Inc.|BEAT - Long-Term Debt to Capital|Short-Term Debt to Capital HeartBeam Inc|BEAT - Company Debts|Debt to Book Value HeartBeam|BEAT - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings HeartBeam|Interim Coverage Ratio heartbeam.com
- financial results and valuation multiples details:
BEAT - Company Net Income|Net Profit Forecast HeartBeam, Inc.|BEAT - P/E Multiple|Projected Price to Earnings heartbeam.com|BEAT - Price/Earnings to Growth Multiple|Total Company Value to Operating Income Before Depreciation Ratio HeartBeam|BEAT - Operating profit EBITDA|Earnings per share for the last twelve months HeartBeam|BEAT - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months heartbeam.com|BEAT - Earnings growth in current year|Earnings growth forecast for next year HeartBeam, Inc.
Analysis of all company metrics:BEAT - HeartBeam Corporation
Manufactured product of HeartBeam

HeartBeam, Inc. is commercializing a patented rapid diagnostic system for myocardial infarctions, establishing a foundation for long-term royalty payments. This metric digitizes the net cash flow from these operations by excluding non-cash expenses, allowing investors to use absolute EBITDA trends to decouple the real fundamental stability of the medical business from short-term market fluctuations and macro-cycle volatility.

Competitor analysis for HeartBeam, Inc.

Operating profit EBITDA Regeneron Corp REGN|IRTC - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization LNTH (lantheus.com)|MLYS (Mineralys Therapeutics, Inc.) - Operating profit before deduction of amortization|HTFL: Company profit before taxes, interest and amortization|KMTS (Kestra) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization ESPR|Operating profit EBITDA AMRN|AVR - Profit before interest, taxes and amortization|Operating profit EBITDA TNYA (Tenaya Therapeutics, Inc.)|Operating profit EBITDA CVRx Inc. CVRX|MIST - Profit before payment of interest, taxes and amortization|Cardiol Therapeutics (CRDL) - Operating profit before deduction of amortization|TENX (Tenax Therapeutics) - Operating profit before deduction of amortization|adagiomedical.com - Income before deduction of interest, taxes and amortization|BCDA (BioCardia) - Operating profit EBITDA|Catheter Precision Inc (VTAK) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization ARCA Biopharma (ABIO)|acastipharma.com - Operating profit before amortization|Operating profit EBITDA AVTE (Aerovate Therapeutics)|VERV - Operating profit before deduction of amortization|WINT: Operating profit before deduction of amortization